Reduced Intellectual Development in Children with Prenatal Lead Exposure by Schnaas, Lourdes et al.
Prospective lead studies of child development
from the 1980s to date show associations
between low blood lead (BPb) concentration
and poor neurobehavioral development
(Baghurst et al. 1992; Bellinger 1989; Bellinger
et al. 1986, 1987, 1994; Bornschein et al.
1985; Dietrich 1991; Dietrich et al. 1987a,
1987b, 1991, 1993a, 1993b; McMichael et al.
1988, 1992; Schnaas et al. 2000; Wasserman
et al. 1992, 1994, 1997, 2000a, 2000b),
although the focus of most of these studies has
been postnatal exposure. Only some studies
included measurement of maternal BPb during
pregnancy or at delivery (Bornschein et al.
1985; Graziano et al. 1990; Rothenberg et al.
1994). A Yugoslavia study (Wasserman et al.
2000a) used a repeated-measures design and
found that increased mid-pregnancy BPb
(12–20 weeks) was signiﬁcantly associated with
decreased 3- to 7-year intelligence quotient
(IQ) regardless of pattern of postnatal exposure.
A Cincinnati, Ohio (USA), study (Ris et al.
2004) showed lasting signiﬁcant effects of BPb
between 6 and 28 weeks on factor scores repre-
senting attention and visuoconstruction in ado-
lescents when prenatal BPb was tested without
simultaneously considering postnatal BPb
exposure history.
Ideally, we would like to include the
entire history of lead exposure in assessing
lasting effects of lead on child development.
When the study sample is exposed to rela-
tively constant sources of environmental lead,
there is often substantial tracking of BPb over
time (Tong et al. 1996; Wasserman et al.
2000a), producing high correlations among
serial BPb levels between and within prenatal
and postnatal periods. Collinearity among
highly correlated BPb variables in the same
linear model will produce biased estimates of
lead effect with inflated SEs. On the other
hand, piecemeal analysis of lead effects, test-
ing one period of lead exposure at a time,
ignores potential effects of earlier or later
exposure. Such omission could lead to resid-
ual confounding of tested lead effects.
The principal lead exposure sources in
pregnant women and their children in the
Mexico City Prospective Lead Study were air
lead and lead from ceramic ware (Schnaas et al.
2004). Air lead decreased continually through-
out the 15-year study period because of reduc-
tion and elimination of lead in gasoline.
Individual exposure to leaded ceramic ware
was both idiosyncratic and intermittent. Such
variable individual lead exposure substantially
reduced BPb tracking in this sample and
allowed an analysis of the effect of lead expo-
sure from 12 weeks of pregnancy through the
ﬁrst 10 years of life on child intelligence from
6 to 10 years of age.
Materials and Methods
Subjects. The subjects belonged to a cohort of
children born in Mexico City at the National
Institute of Perinatology between 1987 and
1992, followed until 2002. The Ethics
Committee of the National Institute of
Perinatology approved the research protocol.
Investigators met with parents, verbally
explained the project, and asked them to read
the description in the informed consent and to
sign if they wished to participate with their
child. We recruited women at 12 weeks of
pregnancy and measured BPb every 8 weeks to
delivery. We also measured BPb from maternal
and cord blood at delivery. A total of 321 chil-
dren born to these women met the following
inclusion criteria: child born with at least
36 weeks of gestational age, 5-min Apgar score
≥ 6, birth weight > 2,000 g, without major or
minor congenital anomalies or being the prod-
uct of multiple birth. We evaluated children
with psychometric tests, anthropometric mea-
surements, and BPb at 6-month intervals after
birth. We collected data on demographic,
socioeconomic, and other factors that might
constitute potential confounders or important
control variables modifying the relationship
between lead and child development.
Of the 321 infants comprising the original
sample, we successfully tested 175 children
after 5 years of age.
BPb measurements. Venous blood was
drawn into purple-top Becton-Dickinson
Vacutainers (Franklin Lakes, NJ, USA) with
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OBJECTIVE: Low-level postnatal lead exposure is associated with poor intellectual development in
children, although effects of prenatal exposure are less well studied. We hypothesized that prenatal
lead exposure would have a more powerful and lasting impact on child development than postnatal
exposure. 
DESIGN: We used generalized linear mixed models with random intercept and slope to analyze the
pattern of lead effect of the cohort from pregnancy through 10 years of age on child IQ from 6 to
10 years. We statistically evaluated dose–response nonlinearity. 
PARTICIPANTS: A cohort of 175 children, 150 of whom had complete data for all included covari-
ates, attended the National Institute of Perinatology in Mexico City from 1987 through 2002.
EVALUATIONS/MEASUREMENTS: We used the Wechsler Intelligence Scale for Children–Revised,
Spanish version, to measure IQ. Blood lead (BPb) was measured by a reference laboratory of the
Centers for Disease Control and Prevention (CDC) quality assurance program for BPb. 
RESULTS: Geometric mean BPb during pregnancy was 8.0 µg/dL (range, 1–33 µg/dL), from 1
through 5 years was 9.8 µg/dL (2.8–36.4 µg/dL), and from 6 through 10 years was 6.2 µg/dL
(2.2–18.6 µg/dL). IQ at 6–10 years decreased signiﬁcantly only with increasing natural-log third-
trimester BPb (β = –3.90; 95% conﬁdence interval, –6.45 to –1.36), controlling for other BPb and
covariates. The dose–response BPb–IQ function was log-linear, not linear–linear. 
CONCLUSIONS: Lead exposure around 28 weeks gestation is a critical period for later child intellec-
tual development, with lasting and possibly permanent effects. There was no evidence of a thresh-
old; the strongest lead effects on IQ occurred within the ﬁrst few micrograms of BPb. 
RELEVANCE TO CLINICAL PRACTICE: Current CDC action limits for children applied to pregnant
women permit most lead-associated child IQ decreases measured over the studied BPb range.
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29 December 2005]EDTA anticoagulant. Environmental Science
Associates Laboratories Inc. (Chelmsford, MA,
USA) determined BPb in duplicate analysis by
anodic stripping voltammetry. Samples with
mean duplicate values < 5 µg/dL were reana-
lyzed via atomic absorption spectrometry.
Quality control information is provided else-
where (Rothenberg et al. 1994). The lab is a
reference laboratory for the Centers for Disease
Control and Prevention (CDC) Blood Lead
Laboratory Reference System (Atlanta, GA,
USA) and participates in the Commonwealth
of Pennsylvania Department of Health Blood
Lead Proﬁciency Testing Program (Exton, PA,
USA). BPb during pregnancy was measured
every 8 weeks starting at week 12 of pregnancy.
We used the geometric mean of lead at 12 and
20 weeks as the lead measure for the second
trimester of pregnancy and the geometric mean
of lead at 28 and 36 weeks as the lead measure
for the third trimester of pregnancy. We calcu-
lated geometric mean BPb from biannual mea-
surements from 6 months to 5 years and used
BPb at each age from 6 to 10 years to measure
lead exposure contemporaneous with each
year’s IQ measurement. In supplementary
models, we also used maternal BPb at each pre-
natal measurement and postnatal geometric
mean yearly BPb from 1 to 5 years.
Developmental assessment. We assessed
child intelligence under standardized condi-
tions with the Wechsler Intelligence Scale for
Children–Revised (WISC-R; Spanish version)
(Wechsler 1981a), providing a Full-scale IQ
(FSIQ). The WISC-R has 12 subtests, six of
which are used to estimate a Verbal IQ
(VIQ), and the remaining six a Performance
IQ (PIQ). Three psychologists unaware of
child BPb evaluated IQ. For each child evalu-
ated by a psychologist, the two other psychol-
ogists reviewed the test protocols and assigned
scores given by the examiner for each test. An
analysis of variance with post hoc testing for
mean IQ grouped by examining psychologist
and child age was used to assess possible
psychologist bias.
Covariates. We measured maternal IQ
with the Wechsler Adult Intelligence Scale
(Spanish) (Wechsler 1981b). We constructed
an index for socioeconomic status (SES) based
on head of household education and occupa-
tion, and family income. We evaluated degree
of stimulation and quality of caretaker–child
interaction in the home environment using
the HOME Scale (Home Inventory for
Families of Infants and Toddlers) (Caldwell
and Bradley 1984). All covariates used in sta-
tistical analyses were collected during preg-
nancy or in the ﬁrst 6 postpartum months.
Data analyses. We used Fisher exact tests,
Pearson chi-squared with exact probability, or
t-tests to contrast subjects included in the
analysis, subjects lost to follow-up in the ﬁrst
5 postnatal years, and subjects with incomplete
post-5-year data with the variables sex,
SES, BPb at different ages, maternal IQ
and educational level, and postnatal develop-
mental scores.
Descriptive statistics, identification of
outliers, and appropriate transformations
were performed before bivariate and multi-
variate analyses. BPb was converted to natural
logarithms to eliminate heteroskedasticity and
normalize skewed distributions of residuals,
reduce the inﬂuence of outlying high lead val-
ues on regression coefﬁcients, and adequately
specify the functional relation of BPb on
FSIQ. We examined associations between the
FSIQ measured from 6 to 10 years of age and
each measurement of lead exposure in panel
regression analyses (Kennedy 2003), first
without covariates and then controlling by
child sex, SES, maternal IQ, HOME, and
birth weight, instead of bivariate regressions,
to adjust the regressions for repeated measure-
ments of IQ in each subject.
Because the data are multilevel with BPb
at each age nested within children, we used a
linear mixed model to analyze the pattern of
lead effect on FSIQ evaluated from 6 to 10
years of age. The dependent variable was
FSIQ at ages 6, 7, 8, 9, and 10, whereas the
independent variables with ﬁxed effects were
maternal IQ, child sex, SES, birth weight,
geometric mean of BPb during the first 5
years of age, BPb at each age at which the
FSIQ measurements were made, geometric
mean of BPb during the second and third
trimester of pregnancy, and a dummy variable
indicating the ﬁrst FSIQ measurement of the
child, allowing control for test learning
between the first IQ measurement and the
following ones. Some children had their ﬁrst
WISC-R test at 6 years of age; others were
ﬁrst tested at 7 or 8 years.
We included as random effects subject
and BPb measured at each year of WISC-R
FSIQ measurement of the child. We modeled
the covariance matrix of the residual error by
a first-order autoregressive process. We used
the likelihood ratio test to determine if the
addition of random intercepts, random
slopes, and autoregressive residual covariance
matrix signiﬁcantly improved model ﬁt.
To examine the effect of simultaneous
inclusion of all lead variables, we constructed
several mixed models each with only one lead
variable and statistically compared those lead
coefficients with the lead coefficients of the
mixed model with all lead variables. We also
constructed mixed models without the con-
trol variables to determine lead coefficients
unadjusted for covariates. We performed the
same analyses for VIQ and PIQ.
We used the Bayesian Information
Criterion (Hardin and Hilbe 2001) to deter-
mine which model best ﬁt the data. The infor-
mation criterion includes a penalized function
based on number of estimated parameters. If
the number of parameters increases without
substantial model improvement, the informa-
tion criterion also increases, indicating a poorer
data ﬁt.
The two-level model had two different
residuals: level-1 residuals, annual observa-
tions calculated by subtracting the linear pre-
dictor from the FSIQ; and level-2 residuals,
the empirical Bayes predictions considered as
higher-level residuals.
To check the normality of the two residual
types, we generated kernel density plots with
overlaid normal density functions and plotted
quartiles of the residuals against quartiles of a
normal distribution to emphasize possible
non-normality near the tails. Shapiro-Wilk
and Shapiro-Francia tests were also used to
check residual normality. We divided level-2
residuals by the SEs (from the posterior SDs)
to detect outliers and plotted residuals against
predictions to examine homoskedasticity.
In addition to calculating correlations
among BPb variables to assess potential for
collinearity, we also ran an artiﬁcial multiple
regression with the full mixed-model variables
to calculate the variance inﬂation factors (VIFs)
(Hardin 1995) for the lead terms. As a final
check on the possibility that collinearity among
lead variables signiﬁcantly affected the pattern
of results in the mixed model, we converted the
group of lead variables to orthogonal variables
and ran the model again.
We reﬁt the mixed models with linear lead
terms and used the J-test (MacKinnon 1981)
to determine if the logarithmic speciﬁcation of
the lead variables produced a better ﬁt to the
data than a linear lead speciﬁcation.
Results
From the sample of 175 children retained to
6 years of age, we studied 150 with complete
data for all covariates included in the model.
There were no significant differences in sex,
SES, birth weight, FSIQ of the child, mater-
nal IQ, BPb at second trimester, and geomet-
ric mean BPb from 1 to 5 years of age
between children included and not included
in the analyses (Table 1). BPb in the third
trimester of pregnancy and at 9 and 10 years
of age was significantly lower in the group
with complete data.
More of the group dropping out before
reaching 6 years tended to be in the lowest
SES, compared with the tested group with
complete data. Bayley (1969) and McCarthy
(1972) developmental scores also tended to be
lower for this group.
The Pearson correlation between the 12-
to 20-week and 28- to 36-week prenatal nat-
ural log BPb was 0.48, between either of the
prenatal and any of the postnatal BPb ≤ 0.23,
and between the 1- to 5-year and 6- to 10-year
postnatal BPb = 0.70. VIFs for all variables in
Schnaas et al.
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where VIF ≥ 10 is considered significant
(Chaterjee et al. 2000). Models using orthogo-
nal lead variables showed no change in model
results. Collinearity among simultaneously
included lead variables in the models was not a
factor in the results presented below. Figure 1
shows the distribution of BPb from the cohort
followed to 6–10 years of age.
Fixed-effects panel regression analyses,
unadjusted for covariates, testing separate pre-
natal, perinatal, and postnatal BPb with FSIQ
of the child showed IQ reduction associated
with BPb increase for all lead measurements
(Table 2). However, the only signiﬁcant BPb
effects were with BPb at third trimester of
pregnancy and BPb measured simultaneously
with IQ tests.
We performed panel analyses for FSIQ
with each of the other covariates alone. All
covariates were associated with IQ in the
expected direction, but only maternal IQ (p <
0.001), maternal educational level (p < 0.001),
SES (p < 0.01), and HOME score (p < 0.05)
showed positive signiﬁcant effects on the FSIQ
of the child (analyses not shown).
Using a linear mixed model with random
intercept and random slope for 6- to 10-year
BPb and adjusting for all covariates (Table 3,
model A), we found that children whose
mothers had higher BPb during 28–36 weeks
of pregnancy had significantly lower FSIQ,
children of the higher IQ mothers had higher
FSIQ at all ages, and child FSIQ in the ﬁrst
evaluation was signiﬁcantly lower than in sub-
sequent evaluations. Most other remaining
Pregnancy lead exposure and child IQ to 10 years of age
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Table 1. Comparison among subjects included in the model and subjects with incomplete data, or not assessed beyond 5 years of age.
Not assessed beyond 5 years of age Subjects with incomplete data Subjects included in the model
Characteristics No. (%) BPb GM (5th–95th)a No. (%) BPb GM (5th–95th)a No. (%) BPb GM (5th–95th)a p-Valueb p-Valuec
Sex
Male 83 (56.8) 12 (48.0) 79 (52.7) 0.49d 0.67d
Female 63 (43.2) 13 (52.0) 71 (47.3)
SES
Lowest 60 (42.9) 3 (12.0) 20 (13.3) < 0.001d 0.82d
Medium 77 (55.0) 16 (64.0) 93 (62.0)
Highest 3 (2.1) 6 (24.0) 37 (24.7)
Apgar 5 min
6 1 (0.7) 0 (0.0) 1 (0.7) 0.98d 1.00d
7 1 (0.7) 0 (0.0) 0 (0.0)
8 8 (5.6) 1 (4.0) 9 (6.0)
9 134 (93.1) 24 (96.0) 139 (92.6)
10 0 (0.0) 0 (0.0) 1 (0.7)
Birth order
1 62 (42.8) 11 (44.0) 73 (48.7) 0.42d 0.87d
2 49 (33.8) 9 (36.0) 48 (32.0)
3 28 (19.3) 3 (12.0) 22 (14.7)
4 4 (2.8) 2 (8.0) 7 (4.7)
≥ 5 2 (1.3) 0 (0.0) 0 (0.0)
Birth weight (g) 144 3,194 (2,503–4,000) 25 3,148 (2,569–3,818) 150 3,218 (2,450–3,911) 0.64 0.46
Maternal IQ 127 91 (68–113) 25 96 (65–115) 150 93 (71–112) 0.31 0.26
Prenatal lead
12–20 weeks 126 8.4 (7.6–9.1) 10 8.2 (3.0–13.7) 150 8.2 (3.0–20.7) 0.20 0.98
28–36 weeks 129 7.3 (1.5–17.4) 11 13.0 (5.3–27.0) 150 7.8 (2.5–24.6) 0.49 0.02
Bayley Scales of Infant Development
MDI at 6 months 122 115.0 (91–140) 20 117.4 (98–137) 135 115.3 (89–144) 0.87 0.60
MDI at 12 months 103 114.1 (94–134) 25 115.2 (86–131) 137 115.7 (93–134) 0.33 0.85
MDI at 18 months 87 104.3 (78–128) 23 112.3 (102–128) 139 107.9 (88–128) 0.05 0.11
MDI at 24 months 69 103.5 (79–132) 21 119.8 (94–150) 135 109.5 (87–132) 0.009 0.003
McCarthy Scale
GCI at 36 months 37 97.6 (64–117) 22 102.0 (89–118) 133 100.8 (85–116) 0.11 0.61
GCI at 42 months 25 98.7 (82–118) 20 110.1 (101–122) 133 105.1 (86–121) 0.01 0.06
GCI at 48 months 30 93.8 (60–130) 24 105.5 (85–119) 137 102.3 (81–122) 0.003 0.26
GCI at 54 months 18 95.8 (57–129) 22 106.8 (88–120) 124 104.1 (89–119) 0.008 0.29
GCI at 60 months 15 98.9 (62–127) 18 108.8 (82–121) 126 104.8 (88–119) 0.048 0.12
WISC FSIQ (years of age)
6 23 109 (91–126) 140 105 (87–123) 0.17
7 20 109 (88–127) 140 109 (91–127) 0.93
8 21 109 (90–130) 127 108 (91–126) 0.72
9 16 114 (98–141) 120 109 (91–128) 0.09
10 15 112 (94–140) 115 109 (87–130) 0.45
Postnatal lead (years of age)
1 131 10.0 (3.2–18.8) 23 11.6 (5.5–19.8) 142 10.8 (4.0–22.0) 0.40 0.54
2 93 12.0 (4.2–25.2) 25 13.1 (5.8–23.0) 142 12.8 (5.0–25.8) 0.42 0.82
3 52 11.6 (5.0–23.5) 25 12.2 (5.2–19.8) 140 11.3 (4.7–22.9) 0.74 0.52
4 38 8.9 (3.2–18.5) 25 11.3 (4.8–19.0) 142 10.3 (4.2–20.5) 0.13 0.46
5 22 9.0 (3.5–16.5) 22 10.6 (5.0–19.2) 136 9.3 (3.8–18.0) 0.78 0.26
6 21 9.3 (4.5–20.8) 135 7.9 (3.2–16.0) 0.14
7 21 8.9 (4.2–17.0) 142 7.5 (3.0–13.8) 0.13
8 20 7.5 (2.5–14.6) 132 6.4 (2.8–12.8) 0.17
9 21 7.7 (3.5–12.5) 123 6.0 (2.8–11.8) 0.025
10 15 7.8 (3.0–19.2) 118 5.6 (2.5–11.2) 0.008
Abreviations: GCI, General Cognitive Index; GM, geometric mean; MDI, Mental Development Index.
aPercentiles. bSubjects included in the model versus subjects not assessed beyond 5 years of age. cSubjects included in the model versus subjects with incomplete data. dFisher’s exact
test of Pearson chi-square exact probability. Unmarked probabilities by t-test for independent samples.covariates were associated with child intelli-
gence in the expected direction but were not
signiﬁcant.
We developed additional models contain-
ing all prenatal and postnatal BPb with only
the covariates that were signiﬁcant in the full
linear mixed model (maternal IQ and the
dummy variable for the first FSIQ measure-
ment of the child). Nonsigniﬁcant BPb vari-
ables were eliminated, so the model then
included only signiﬁcant covariates (Table 3,
model D). The third-trimester BPb coeffi-
cients in all additional models with progres-
sive deletion of nonsignificant variables
(Table 3, models B, C, and D) were not sig-
niﬁcantly different from the coefﬁcient found
in the full mixed model (Table 3, model A),
also suggesting minimal collinearity effects.
In the linear mixed model with VIQ as
the dependent variable, higher 28- to 36-week
BPb was associated with lower intellectual
coefﬁcient of the child (β = –3.15, p = 0.007),
and children of higher IQ mothers had better
performance (β = 0.29, p < 0.001). There was
no significant change in the VIQ from the
ﬁrst evaluation to subsequent evaluations.
In the linear mixed model with PIQ as the
dependent variable, 28- to 36-week BPb was
inversely associated with child IQ (β = –4.37,
p = 0.004), and children of the higher IQ
mothers had better performance (β = 0.40, p <
0.001). We also observed significant PIQ
improvement from first to subsequent tests
(β = 7.2, p < 0.001).
To evaluate more precisely at which preg-
nancy stage maternal BPb was best associated
with later reduction in child IQ, we con-
structed a linear mixed model adjusted by the
same covariates used in the full linear mixed
model (Table 3, model A) but exchanged the
averaged prenatal BPb variables for prenatal
BPb at week 12, 20, 28, or 36 of pregnancy.
BPb at week 28 of pregnancy was the only
prenatal lead measure signiﬁcantly predicting
lower FSIQ (β = –4.13, p < 0.001) (Table 4).
To statistically test whether natural log
BPb transformation fit the data significantly
better than a linear BPb specification, we
used the J-test to compare the two speciﬁca-
tions of lead at the third trimester of preg-
nancy on FSIQ in the full model (Table 3,
model A). The logarithmic form of third-
trimester BPb ﬁt the data signiﬁcantly better
than did a linear functional form (t = 2.15,
p = 0.02).
Figure 2 shows a partial residual plot of the
effect of third-trimester maternal BPb on FSIQ
at 8 years of age adjusted for the covariates and
Schnaas et al.
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Figure 1. Box plots of BPb by age of the 150 children
sampled for the linear mixed-model analyses. The
lower and upper limits of the rectangular boxes
indicate the 25th to 75th percentile range, and the
horizontal line within the boxes is at the 50th per-
centile. The vertical lines extending from the bottom
and top of the boxes represent lead values 1.5 times
the interquartile range below and above the 25th
and 75th percentile, respectively. Open circles rep-
resent lead values between 1.5 and 3.0 times the
interquartile range below and above the 25th and
75th percentile, and pluses indicate lead values
exceeding 3.0 times the interquartile range limit.
Plots for each age, with extreme high values, are
typical for log distributions plotted on a linear scale.
Conversion factor: 10 µg/dL = 0.483 µmol/L.
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Table 2. Nonadjusted and adjusted models of FSIQ (panel regressions). 
Unadjusted Adjusteda
Lead variable (µg/dL) No. β 95% CI p-Value (two-tailed) βadj 95% CI p-Value (two-tailed)
Ln(lead) 12–20 weeks 150 –1.90 –4.79 to 0.98 0.20 –1.45 –4.75 to 2.00 0.42
Ln(lead) 28–36 weeks 150 –3.84 –6.24 to –1.44 0.002 –4.00 –6.37 to –1.65 0.001
Maternal ln(lead) delivery 112 –1.77 –5.12 to 1.57 0.29 –1.29 –4.41 to 1.83 0.41
Umbilical cord ln(lead) 109 –0.69 –3.50 to 2.11 0.63 –0.95 –3.65 to 1.75 0.49
Mean ln(lead) (1–5 years) 150 –2.41 –6.38 to 1.57 0.23 0.49 –3.81 to 4.81 0.82
Ln(lead) at 1 year of age 142 –1.51 –4.96 to 1.94 0.39 0.51 –3.19 to 4.21 0.79
Ln(lead) at 2 years of age 143 –1.10 –4.49 to 2.29 0.39 0.91 –2.67 to 4.49 0.62
Ln(lead) at 3 years of age 140 –2.53 –6.22 to 1.15 0.18 –0.58 –4.53 to 3.37 0.78
Ln(lead) at 4 years of age 142 –0.61 –4.34 to 3.12 0.75 1.17 –2.67 to 5.02 0.55
Ln(lead) at 5 years of age 136 –2.96 –6.67 to 0.75 0.12 –0.32 –4.26 to 3.36 0.87
Mean ln(lead) (1–2 years) 147 –1.78 –5.46 to 1.90 0.34 0.60 –3.36 to 4.57 0.76
Mean ln(lead) (3–5 years) 150 –2.63 –6.47 to 1.22 0.18 –0.08 –4.15 to 3.98 0.96
Mean ln(lead) (6–10 years) 150 –2.70 –4.23 to –1.16 0.001 –2.45 –4.09 to –0.81 0.003
CI, conﬁdence interval. Each lead variable was tested alone.
aAdjusted by maternal IQ, SES, sex, birth weight, an indicator variable of ﬁrst FSIQ application at 6, 7, or 8 years.
Table 3. Linear mixed models of FSIQ with random intercept and random slope for 6–10 year BPb (µg/dL): ﬁxed-effects estimations.
Model B (without nonsigniﬁcant Model C (model B without  Model D (without any
Model A (full model) control variables) nonsigniﬁcant lead before 6–10 years) nonsigniﬁcant variables)
Variable β 95% CI p-Valuea β 95% CI p-Value β 95% CI p-Value β 95% CI p-Value
Intercept 73.6 52.4 to 94.6 < 0.0001 73.6 56.9 to 90.4 < 0.0001 75.8 62.6 to 88.0 < 0.0001 76.3 63.7 to 88.9 < 0.0001
Mean ln(lead) 12–20 weeks 1.02 –1.98 to 4.03 0.50 0.89 –2.09 to 3.88 0.56
pregnancy (µg/dL)
Mean ln(lead) 28–36 weeks –3.90 –6.45 to –1.36 0.0029 –3.85 –6.36 to –1.33 0.0029 –3.46 –5.64 to –1.29 0.0020 –3.44 –5.61 to –1.28 0.0020
pregnancy (µg/dL)
Mean ln(lead) 1–5 years (µg/dL) 0.10 –3.88 to 4.06 0.96 0.35 –3.48 to 4.18 0.86
Ln(lead) 6–10 years (µg/dL) 0.17 –1.41 to 1.76 0.83 0.15 –1.44 to 1.72 0.86 0.21 –1.30 to 1.72 0.79
Child sex (female) –1.51 –4.75 to 1.73 0.36
Birth weight (g) 0.001 –0.003 to 0.004 0.61
SES (tertiles) –0.38 –1.86 to 1.10 0.61
Maternal IQ 0.40 0.26 to 0.55 < 0.0001 0.39 0.26 to 0.52 < 0.0001 0.39 0.26 to 0.51 < 0.0001 0.38 0.26 to 0.51 < 0.0001
First FSIQ measurement –4.00 –4.84 to –3.16 < 0.0001 –4.00 –4.82 to –3.15 < 0.0001 –4.00 –4.83 to –3.16 < 0.0001 –4.00 –4.78 to –3.16 < 0.0001
CI, conﬁdence interval.
aTwo-tailed.other BPb values in the full model (Table 3,
model A).
Discussion
Increased maternal lead concentration at third
trimester of pregnancy, especially around week
28, was associated with decreased intellectual
child development, even after controlling for
other prenatal and postnatal lead measure-
ments. Other studies found signiﬁcant adverse
associations between postnatal BPb and IQ
(Baghurst et al. 1992; Bellinger et al. 1992;
Dietrich et al. 1993b; Wasserman et al. 1997).
In our panel unadjusted regression analyses, we
noted a signiﬁcant effect of 6- to 10-year BPb
on child IQ as well, but this effect lost signiﬁ-
cance when other BPb and covariates were
included in mixed-model analysis. Collinearity
between prenatal and 6- to 10-year BPb vari-
ables was not responsible for loss of explana-
tory power of 6- to 10-year BPb, as shown in
the extensive diagnostic testing reported in
“Results.” Given the modest sample size and
relatively low power of this study, we do not
claim that lead exposure from 6 to 10 years or
any other developmental period has no effect
on child IQ. More likely, third-trimester lead
exposure is a more powerful predictor of later
child IQ and absorbed enough of the variation
in IQ formerly attributed to 6- to 10-year BPb
to render it insigniﬁcant in our model.
In contrast to other studies in which
prenatal lead exposure biomarkers were
umbilical cord BPb (Bellinger et al. 1992) or
one (Dietrich et al. 1993b; Ris et al. 2004;
Wasserman et al. 1997, 2000a) or at most two
(Baghurst et al. 1992) maternal lead measure-
ments during pregnancy, we measured prena-
tal lead exposure systematically (within an
interval of ± 2 weeks) during specific preg-
nancy stages (weeks 12, 20, 28, and 36 of
pregnancy, at delivery, and in umbilical cord).
We note that 28-week fetal central nervous
system development is distinctly different than
development either at 12 weeks or at term.
Neuroblast proliferation is essentially complete
before 28 weeks, whereas neuronal migration
and aggregation continue through the ﬁrst half
of the third trimester. Myelination of tracts
within the developing human fetal brain has
just begun by 25 weeks (Herschkowitz 1988).
Deeper cortical layers are poorly defined at
24 weeks, clearly developed at 28 weeks, and
reach postnatal appearance by 34 weeks of
pregnancy (Larsen 1997). Limiting the range
of permitted weeks of pregnancy for placing
each maternal BPb in its nominal category
probably enhanced our ability to detect
pregnancy phase-speciﬁc BPb effects.
Other studies did not simultaneously
include all lead measurements in their analy-
ses, although one (Wasserman et al. 2000a)
included directional postnatal lead change
indicators along with the single pregnancy
BPb variable. We were able to include the
entire history of lead exposure in our analyses
because collinearity among the lead measures
was not a significant factor. In our analysis,
simultaneous inclusion of 6- to 10-year BPb
and the remaining BPb reduced the size of
the 6- to 10-year lead coefficient without
changing its variance, rendering it insignifi-
cant. With the increased power afforded by a
larger sample size, 6- to 10-year BPb might
well have retained its signiﬁcance.
Methodologic considerations. A frequent
problem in cohort studies is high loss rate
during extended follow-up. From an original
sample of 321 children, we tested 175 avail-
able children after 5 years of age, of which
only 150 were included in mixed-model
analyses due to missing covariates. The
smaller number of subjects reduced the possi-
bility of detecting subtle effects and increased
the possibility of instability of model coeffi-
cients. Nevertheless, despite the medium sam-
ple size, we found a highly signiﬁcant effect of
maternal third-trimester BPb on child IQ at
6–10 years of age with little evidence of selec-
tive dropout bias in the descriptive statistics.
In addition to longitudinal analyses, we
carried out separate analyses of IQ at each
age. The pattern of results was consistent in
these analyses; 28- to 36-week BPb and
maternal intellectual quotient were the vari-
ables signiﬁcantly predicting child IQ.
Repeated use of the same test to evaluate
child IQ at short intervals could lead to learn-
ing of test components across time and a
familiarization with the test situation. We
found a significant change (Table 3) only
between the ﬁrst FSIQ measurement and the
subsequent measurements, nearly all of which
was due to increase in the performance scale.
Repeated test application produced a signiﬁ-
cant adjusted increase of 7.2 PIQ points and
4.0 FSIQ points from ﬁrst to subsequent test
applications. This might be expected in chil-
dren encountering performance tasks for the
ﬁrst time during the initial test application.
Studies in developmental toxicity have
shown that subtle developmental alterations
are easier to detect when subjects confront
challenging or stressful situations (Cory-
Slechta 1990; Rice and Baron 2000).
Familiarity with the test situation and repeti-
tion of the same test should have reduced our
ability to detect subtle developmental deﬁcits
associated with lead. We conclude that the
lead effect described is robust.
Other studies found a substantial impact
of sociodemographic variables on IQ. Several
studies reported significant associations
between lead and child development that dis-
appear (Ernhart et al. 1989) or become evi-
dent (Wasserman et al. 1997) when HOME
score was used as a covariate. We applied the
6-month HOME Scale in our study but did
not include it in full modeling because it did
not appreciably or significantly change the
estimated magnitude and signiﬁcance of BPb
and because model ﬁt improved according to
the Bayesian Information Criterion (Hardin
and Hilbe 2001) when this covariate was
omitted (see Appendix for mixed models with
HOME added). In contrast to our models,
other studies found the HOME Scale useful.
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Table 4. Linear mixed model of FSIQ with random intercept and random slope for concurrent lead (n = 122)
Test of prenatal lead concentration at week 28 of pregnancy: ﬁxed-effects estimations.
Variable β 95% CI p-Value (two-tailed)
Intercept 79.5 56.5 to 102.5 < 0.0001
Ln(lead) 28 weeks pregnancy (µg/dL) –4.13 –6.45 to –1.81 0.0006
Mean ln(lead) 1–5 years (µg/dL) –1.01 –5.54 to 3.52 0.66
Ln(lead) 6–10 years (µg/dL) 0.21 –1.46 to 1.88 0.81
Child sex (female) –1.21 –4.87 to 2.45 0.52
Birth weight (g) 0.001 –0.003 to 0.005 0.61
SES (tertiles) –0.40 –1.27 to 2.07 0.64
Maternal IQ 0.38 0.22 to 0.54 < 0.0001
First FSIQ application –3.52 –4.43 to –2.61 < 0.0001
CI, conﬁdence interval.
Figure 2. Partial residual plot of the effect of third-
trimester maternal BPb (thin lines: 95% conﬁdence
interval) on FSIQ at 8 years of age adjusted for
maternal IQ, sex, birth weight, SES, and BPb levels
at other prenatal and postnatal ages. Conversion
factor: 10 µg/dL = 0.483 µmol/L.
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tThe HOME Scale is distinctly Euro-North
American culture bound. For example, we
found that many homes we visited did not
have items such as educational toys, which
were not readily available in the domestic
market at that time, thus altering the HOME
score of our subjects. Furthermore, 6-month
evaluations might be expected to play little
role in development at 6–10 years.
If increased third-trimester BPb levels were
associated with decreased birth weight and low
birth weight was associated with poor postnatal
intellectual development, the modeled effect of
third-trimester BPb on 6- to 10-year IQ could
be mediated through lead effect on birth
weight. Our subject inclusion criteria accepted
only newborn infants into the study with birth
weight > 2,000 g (the Mexican standard for
low birth weight at the time of the study), thus
excluding cases with the highest probability of
showing later deﬁcits due to low birth weight.
Exploratory modeling showed that no prenatal
BPb was significantly associated with birth
weight. Finally, excluding or including birth
weight in mixed-model analyses changed the
28- to 36-week BPb coefficient by less than
0.03. There is no evidence in these data that
third-trimester BPb effect on 6- to 10-year-old
IQ was mediated by lead effect on weight.
Both the Spanish WISC-R for child IQ
and the Spanish Wechsler Adult Intelligence
Scale used for maternal IQ have since been
superseded by updated, renormalized ver-
sions. The tests we used were the only
Spanish language versions available during
data collection. We note that the IQ scores
measured in our sample were generally higher
than those obtained in other prospective stud-
ies, perhaps as a result of using outdated tests.
Although the current version of the WISC
might reveal the bias in the absolute IQ asso-
ciated with lead in these data, the covariation
between BPb and IQ was likely not affected
by the speciﬁc test version used.
Public health implications. These data sug-
gest that the early third trimester of pregnancy
may constitute a critical period for subsequent
intellectual child development, during which
lead exposure can produce lasting and possibly
permanent effects. In addition, the data suggest
there is no threshold for the adverse conse-
quences of lead. On the contrary, the largest
IQ changes in our sample are observed within
the ﬁrst few micrograms per deciliter of BPb—
that is, at lower BPb (Figure 2). The relation-
ship between BPb and child IQ is logarithmic,
not linear, as shown by the significant (p =
0.02) J-test. Other studies have already
reported larger IQ change with change of lead
at lower concentrations than at higher concen-
trations (Canﬁeld et al. 2003; Lanphear et al.
2000; Schwartz 1994). A recent reanalysis of a
large (n = 1,333) pooled data analysis
(Lanphear et al. 2005) of seven prospective
lead studies, including this one, also conﬁrms
that the log-linear dose–response relationship
between IQ around 7 years of age and contem-
porary BPb is superior to a linear–linear
dose–response relationship (Rothenberg and
Rothenberg 2005).
We noted the same pattern of BPb change
during pregnancy in this study (Rothenberg
et al. 1994) observed in other studies in the
United States (Hertz-Picciotto et al. 2000;
Schell et al. 2000). Postnatal BPb pattern with
age has already been examined in detail in this
cohort (Schnaas et al. 2004) and is similar to
that from United States and Australian prospec-
tive studies (Dietrich et al. 1991; McMichael
et al. 1988). Postnatal BPb peaks around
2 years of age and then decreases with increas-
ing age (Figure 1). Because our cohort did not
exhibit unusual BPb change from 12 weeks of
pregnancy through 10 years of age, our results
cannot be attributed to the cohort’s unique
history of lead exposure.
Across a range of BPb from 1 to 32 µg/dL,
these data show that half of the deleterious
effects of lead on child IQ measured here
occurred when third-trimester BPb increased
from 1 to 6 µg/dL. When maternal BPb
reached current Mexican and U.S. action limits
for children and pregnant women (10 µg/dL),
most of the adverse consequences on later child
IQ associated with lead in the measured range
had already occurred. If we continue to accept
the current action limit, we also accept that
most of the “damage” to the IQ of children
associated with third-trimester lead exposure in
our sample is permissible.
The fetal brain seems susceptible to lower
lead concentrations than those established by
the official Mexican standard and current
CDC guidelines, and the effects are obvious at
least until 10 years of age. Although these
ﬁndings should be replicated, our data suggest
that we should establish lower action limits for
lead exposure of reproductively active women.
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